Bridgepoint Medical Inc.

MINNEAPOLIS, August 3, 2011 - BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have enrolled their first patient in the Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions (PFAST-CTOs) study.

MINNEAPOLIS, May 16, 2011 - BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have received clearance of an expanded indication for the CrossBoss(TM) Catheter and Stingray(TM) System from the FDA.

MINNEAPOLIS, March 18, 2011 - BridgePoint Medical, Inc., a Minnesota based medical device company, has announced that Denis Harrington has joined the company as President and Chief Executive Officer.

MINNEAPOLIS, March 10, 2011 - BridgePoint Medical, Inc., a private company developing innovative and proprietary technology in the field of interventional cardiology for crossing coronary and peripheral chronic total occlusions (CTO), announced today that it has completed its third round of financing earlier this year, totaling $9.1 million.

MINNEAPOLIS, October 4, 2010 - BridgePoint Medical, Inc., a medical device company focused on coronary and peripheral catheter-based systems for chronic total occlusion (CTO) recanalization, announced the completion of the FAST-CTOs study.